SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-030842
Filing Date
2024-03-13
Accepted
2024-03-13 16:45:53
Documents
2
Period of Report
2024-03-12

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1569
2 EX-24 pyxs-ex24.htm EX-24 13276
  Complete submission text file 0000950170-24-030842.txt   16263
Mailing Address 321 HARRISON AVENUE BOSTON MA 02118
Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059
Pyxis Oncology, Inc. (Issuer) CIK: 0001782223 (see all company filings)

IRS No.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ACRIVON THERAPEUTICS, INC. 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address
Palani Santhosh (Reporting) CIK: 0002013475 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40881 | Film No.: 24746615